0 Комментарии
0 Поделились
639 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Rivaroxaban Market Advances with Growing Adoption of Novel Oral Anticoagulants for Stroke Prevention and Thrombosis ManagementAccording to the latest report published by Data Bridge Market Research, the Rivaroxaban Market Data Bridge Market Research analyses that the rivaroxaban market, valued at USD 14.89 million in 2022, will reach USD 25.59 million by 2030, growing at a CAGR of 7.0% during the forecast period of 2023 to 2030. An influential Rivaroxaban Market document comprises of a detailed...0 Комментарии 0 Поделились 136 Просмотры 0 предпросмотр
-
The Multi-Billion-Dollar Future of Anticoagulants: Trends, Opportunities, and Competitive InsightsAnticoagulant Market According to the latest report published by Data Bridge Market Research, the Anticoagulant Market Data Bridge Market Research analyses that the anticoagulant market which is USD 60.90 million in 2022, is expected to reach USD 94.17 million by 2030, at a CAGR of 5.6% during the forecast period 2023 to 2030. A number of aspects that are kept into view while...0 Комментарии 0 Поделились 118 Просмотры 0 предпросмотр
-
Fondaparinux Market Expands with Thrombosis Treatment Demand, Generics Entry, and Advanced Anticoagulant UseExecutive Summary Fondaparinux Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses a growth rate in the fondaparinux market in the forecast period 2023-2030. The expected CAGR of fondaparinux market is tend to be around 6.7% in the mentioned forecast period. The market was valued at USD 574.94 million in 2022, and it would grow up to USD 965.91...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rivaroxaban Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032"Keyword Market Summary: According to the latest report published by Data Bridge Market Research, the Rivaroxaban Market Data Bridge Market Research analyses that the rivaroxaban market, valued at USD 14.89 million in 2022, will reach USD 25.59 million by 2030, growing at a CAGR of 7.0% during the forecast period of 2023 to 2030. T This Rivaroxaban Market document encompasses...0 Комментарии 0 Поделились 190 Просмотры 0 предпросмотр
© 2026 Myliveroom — Live Events & Online Communities
Russian